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Abstract
The investigation of nanoparticle interactions with tissues is complex. High levels of standardization, ideally testing of different
material types in the same biological model, and combinations of sensitive imaging and detection methods are required. Here, we
present our studies on nanoparticle interactions with skin, skin cells, and biological media. Silica, titanium dioxide and silver
particles were chosen as representative examples for different types of skin exposure to nanomaterials, e.g., unintended environ-
mental exposure (silica) versus intended exposure through application of sunscreen (titanium dioxide) or antiseptics (silver).
Because each particle type exhibits specific physicochemical properties, we were able to apply different combinations of methods
to examine skin penetration and cellular uptake, including optical microscopy, electron microscopy, X-ray microscopy on cells and
tissue sections, flow cytometry of isolated skin cells as well as Raman microscopy on whole tissue blocks. In order to assess the
biological relevance of such findings, cell viability and free radical production were monitored on cells and in whole tissue samples.
The combination of technologies and the joint discussion of results enabled us to look at nanoparticle–skin interactions and the bio-
logical relevance of our findings from different angles.
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Introduction
The skin is the outermost surface of humans and therefore
easily accessible. The exposure of skin to nanomaterials can be
categorized into unintended exposure to engineered particles
and intended exposure, which includes compounds meant to
stay on the skin surface (sunscreens, antiseptics) or those meant
to enter viable skin (dermatotherapy, cosmetics), respectively.
With the increasing use of nanoscale architectures in all of these
fields, the question as to whether a nanomaterial deposited on
the skin surface is capable of penetrating horny layers and
reaching viable epidermis is of high relevance.
As a result of the special architecture of the skin, levels of inter-
actions include the translocation step across the skin barrier,
cellular uptake as well as biological effects. In fact, biological
responses to nanoparticle exposure may occur on the cellular
level, but also as a result of interactions with the skin microen-
vironment. In the following, we present results obtained from
own studies on the interactions of skin, skin cells and bio-
logical media with silica, titanium dioxide and silver particles as
representatives for nanomaterials of high relevance from the
dermatological perspective.
Results and Discussion
Skin barrier translocation of nanomaterials
The first contact of nanomaterial occurs with the horny layers of
terminally differentiated corneocytes. Pathways across the
intact stratum corneum have been postulated for some, mostly
deformable, particles, such as liposomes or transferosomes.
[1,2]. Although increasing reports suggest that barrier transloca-
tion of solid particles occurs especially when the skin barrier is
disrupted, the penetration of solid particles into the viable
epidermis seems to be limited. Figure 1 illustrates the experi-
mental set-up that we chose in order to investigate skin penetra-
tion of topically applied silica particles (Figure 1a).
Here, conventional fluorescence microscopy of skin sections
yielded no evidence for the penetration of 42–300 nm fluores-
cent silica particles in excised human skin. The data are in
accordance with differential tape stripping studies by our group
[5], which show that for different particle architectures, approx.
95% of the applied particles remain in the upper layers of the
stratum corneum. Because conventional optical microscopy
faces clear limitations due to the lack of spatial resolution, we
conducted scanning transmission X-ray microscopy (STXM)
studies on human skin, which allowed us to visualize silica-
shell/gold-core particles in the size range of 94–298 nm on
superficial layers of the stratum corneum and in hair follicle
openings at the single particle level (Figure 1c, see [4] for
further details). Our results are in line with many other studies
on particles that are in this size range and larger. For example,
in the case of titanium dioxide particles, a deeper penetration
was not detected through microscopy, both for microparticles as
well as for nanoparticulate preparations [6-8]. To generate valid
data, however, it is not sufficient to rely on the penetration
depth alone [9]. A deeper understanding can only be obtained
by combining different approaches. Notably, X-ray microscopy
could become a valuable tool for imaging with high spatial
resolution combined with analysis of spectroscopic data.
Following similar approaches, Adachi et al. performed trans-
mission electron microscopy (TEM) and energy dispersive
X-ray spectroscopy (EDX) measurements on murine skin after
up to 8 weeks of daily sunscreen application with similar results
[10]. However, a loss of particles during fixation and sectioning
poses technical challenges, especially when ultrathin sections
must be prepared for analysis with high resolution techniques,
such as STXM or electron microscopy. Preparation of single-
cell suspensions from tissue samples pretreated with
nanoparticles overcomes challenges associated with fixation
and sectioning. The cells remain intact and can be analyzed by
flow cytometry or single cell microscopy.
For our studies on skin penetration of silica particles, we
prepared single-cell suspensions of skin samples treated with
fluorescent particles and performed flow cytometry and single-
cell microscopy on keratinocytes, Langerhans cells as well as
dermis cell isolates. Although deeper penetration through the
horny layers into the viable epidermis could not or could only
partially be observed even after mild skin barrier disruption by
means of cyanoacrylate skin surface stripping, we were able to
isolate skin cells which had taken up particles from treated ex
vivo human skin (Figure 1d) [3,11]. In accordance with
previous studies, the particle size appeared to be a major deter-
minant for cellular uptake. Notably, after ex vivo topical appli-
cation of silica particles on human skin and subsequent isola-
tion of keratinocytes and Langerhans cells, only the internaliza-
tion of 42 nm, but not of 75 or 200 nm particles could be identi-
fied. Interestingly, the size limit for penetration and cellular
uptake appears to differ among different particle types. In
previous studies of our groups, we observed penetration and
cellular uptake of fluorescent polystyrene particles ranging from
40–200 nm in diameter after skin surface stripping in murine
and human skin [11,12]. Furthermore, the internalization of a
fluorescent vaccinia virus vector (diameter approx. 290 nm)
could be conveniently identified not only in murine hair follicle
epithelium [12], but also in dendritic cells of the skin. In fact,
our earlier studies and results of others suggest that even low
penetration rates of particle-bound antigens may result in
cellular uptake by cutaneous antigen-presenting cells and rele-
vant immune response [12-14]. Furthermore, low penetration
rates may become relevant, when large skin surface areas come
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Figure 1: Interdisciplinary set-up to study skin penetration and cellular uptake of amorphous silica particles in human skin explants. Silica particles
with 42, 75 or 300 nm diameter were applied on excised human skin to study penetration and cellular uptake (a). Labeling of particles with fluorescein
enabled the visualization of particle accumulation on skin sections and in hair follicle openings by using fluorescence microscopy (b). However, single
particles on the skin surface could only be visualized after preparation of silica particles with gold cores and skin section analysis by using scanning
transmission X-ray microscopy (STXM) (c). Whereas particles with a size ranging between 75 and 300 nm accumulated on the horny layers and in
hair follicle openings without deeper penetration, flow cytometry of single cell suspensions prepared from skin tissue pretreated with fluorescent
42 nm particles identified a small percentage of cells associated with particles (d, boxed areas in representative flow cytometry images). Single cell
fluorescence microscopy confirmed the presence of cell-associated particles that are highly suggestive for cellular uptake (e). (Figure 1a,b,d,e modi-
fied with permission from [3], Copyright 2012 American Chemical Society; Figure 1c modified with permission from [4], Copyright 2009 Society of
Photo Optical Instrumentation Engineers.)
in contact with the respective nanomaterial, or when repetitive
exposure occurs over prolonged time periods.
The susceptibility to artefacts also underlines the value of
methods that enable studies on the whole skin, ideally
under in vivo conditions, e.g., in vivo confocal microscopy
and multiphoton microscopy [9]. In earlier studies using
mice, we were able to monitor the penetration of fluorescent
200 nm particles in hair follicles and diffusion into perifollic-
ular tissues in vivo over time [12]. On the other hand, hair folli-
cles were found to be excretion pathways for injected gold
nanoparticles [15].
Raman microscopy is another technique with high spatial reso-
lution which permits such studies. While we gathered first own
results on skin with the in vivo detection of antioxidant levels as
indicators of oxidative stress [16], it is now increasingly being
used to study particle–skin interactions [17,18]. Yet, not all
particle types are equally suited for such investigations. In the
following, we report our results on confocal Raman microscopy
for analyzing the skin penetration of silver nanoparticles
(AgNP, mean size 70 nm) in porcine ear skin. By tracking the
Raman signal of AgNP, the mean penetration depth in intact
skin was found to be 4.4 ± 1.5 µm, which is in accordance with
other investigations on silica [3], zink oxide [19], or AgNP in
Beilstein J. Nanotechnol. 2014, 5, 2363–2373.
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Figure 2: Skin penetration and cellular uptake of silver nanoparticles (AgNP). While studies with silica particles required labeling of particles with fluo-
rescent dyes or introduction of gold cores followed by sectioning of the tissue for further analysis, skin penetration of AgNP could be studied in intact
tissue blocks by tracking of the Raman signal. The representative Raman and SERS typical spectra were obtained in intact porcine skin (depth 4 µm)
pre-treated with AgNP, excitation wavelength 785 nm, power on the sample 25 mW, analyzing range 400–2000 cm−1 (a). Label-free detection of
AgNP also facilitated studies on cellular uptake by HaCaT cells by using TEM. In the representative TEM images of HaCaT cells (obtained after incu-
bation for 24 h with 25 µg/mL AgNP) AgNP are accumulated in endosomes (b–d).
this size range or smaller [20]. A pre-treatment with tape strip-
ping of 20 adhesive tapes, which according to our own unpub-
lished data corresponds to a removal of approximately 70–80%
of the stratum corneum, only slightly increased the penetration
depth to 5.1 ± 2.5 µm. Additionally, the penetration profile of
AgNP was analyzed by the highly sensitive tracking of the
surface enhanced Raman scattering (SERS) signal of single
AgNP. Here, the penetration depth was found to be 19 ± 10 µm
for intact skin, compared to 22 ± 5 µm for skin pre-treated with
20 tape stripes. This effect is well known for AgNP of this type
and size [20]. Results obtained from SERS indicate that single
AgNPs can penetrate deeply into the stratum corneum. The
Raman and SERS spectra of porcine skin pre-treated with
AgNP are shown in Figure 2a.
The results illustrate that for AgNP, the SERS effect can be
used to monitor the skin penetration depth of single particles.
Interestingly, pretreatment of skin with 20 tape strippings
doubled the likelihood to detect a SERS effect. In these
tape-stripped skin samples, the SERS effect was measured deep
in the stratum corneum and in the stratum granulosum
of the viable epidermis. This finding could indicate a
deeper penetration in moderately disrupted skin. However,
secondary translocation through microscopic injuries or
slantingly growing hair follicles has to be excluded. In
fact, the reservoir function of hair follicles for large
molecules and particles is now widely accepted [21,22]. The
extension of the hair follicle canal deep into the dermis can
result in dermal signals, which correspond to particles in such
Beilstein J. Nanotechnol. 2014, 5, 2363–2373.
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Figure 3: Uptake of fluorescent silica nanoparticles with variable size and surface functionalization by HaCaT cells. Different type of particles were
prepared (a–d) with a size of 42 (a,c) or 75 nm (b,d) as well as negative (a,b) or positive (c,d) surface charge through funtionalization with (3-amino-
propyl)triethoxysilane (APS) groups. Cells were incubated with particles (10 µg/mL, 2 h, 37 °C) and analyzed by means of flow cytometry (e,f) and
confocal laser scanning microscopy (g). Cells incubated with non-functionalized (black lines) and APS-functionalized (grey lines) SiO2 particles
showed a positive, particle-related signal with respect to the untreated control cells (filled silver histograms). CLSM (Olympus FV1000) confirmed the
internalization of both particle aggregates and single particles. Inset shows the four fold magnification of the boxed area. (Modified with permission
from [3], Copyright 2012 American Chemical Society.)
follicular depots rather than free particles in dermis. Such
preferred agglomeration and even deep penetration into hair
follicles as well as the retention over several days [23] have
convincingly been shown for many different particle architec-
tures [11,24,25]. Consistently, we also found depot formation
after topical application of fluorescent silica particles. Aggre-
gates retained in the hair follicle are protected from regular
shedding and are prone to intense interactions with hair follicle
epithelium. In studies with polystyrene particles as well as
Modified Vaccinia Ankara Virus as an example for bio-
logically and immunologically relevant particulates in the
context of transcutaneous vaccination, we recently identified
hair follicles as sites of nanomaterial translocation into the
viable tissue, especially when mild skin barrier disruption by
tape stripping techniques was performed additionally [11,12].
Similarly, penetration of cobalt nanoparticles in the size range
of 20–500 nm were found both in intact and abraded human
skin [26-28], while Abdel-Mottaleb et al. confirmed particle
penetration and accumulation in inflamed skin [29]. Also,
combinations of nanomaterial exposure with UV-irradiation,
may be especially deleterious for the skin organ because
UV-exposure may facilitate penetration [30] as shown by
Mortensen et al. for rigid metallic nanoparticles [31]. This can
cause particle disintegration leading to a reduction of the size of
the particles with an increased likelihood of penetration [32] or
it can trigger photocatalytic processes which cause secondary
harm to skin cells [33,34].
Identification of factors which influence
cellular uptake
In our studies, the functionalization of silica particles with
amino groups in order to turn the surface potential of the
particles from initially negative to highly positive did not
significantly affect cellular uptake rates in whole-tissue experi-
ments. However, immortalized human keratinocytes (HaCaT,
Human Adult Low Calcium High Temperature Keratinocytes)
and primary human keratinocytes showed an increased uptake
of silica particles with positive surface charge under cell culture
conditions, which was due to functionalization, e.g., through
(3-aminopropyl)triethoxysilane (APS) (Figure 3) [3].
In the case of these silica particles, such a surface functionaliza-
tion was contrasted by an increased tendency to form aggre-
gates which could explain why barrier translocation did not
occur despite an increased cellular uptake. The results demon-
strate that although surface functionalization may have some
impact on the cellular uptake, particle size and the size of aggre-
gates formed in physiological environments can become
limiting factors. Similar results were obtained for similarly
sized silica particles (55 ± 2 nm) with and without APS-func-
tionalization in HeLa cells [35]. Also in this case, the APS-
functionalized particles were heavily aggregated but still taken
up into cells in large numbers. However, N-(6-aminohexyl)-
aminopropyltrimethoxysilane (AHAPS)-functionalized
particles, which had also a highly positive zeta-potential due to
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the amino groups but did not aggregate in cell culture media
were also found in large numbers in the cells [35]. In our
studies on the stability of differently functionalized silica
particles, even different standard cell culture media compos-
itions resulted in different aggregation behaviors of nanopar-
ticle preparations [35]. The multitude of possible interactions on
the skin surface and in the tissue raises the question whether
nanomaterials ever have the chance to translocate the skin
barrier on the single-particle level, or how the adsorption of
skin surface material and secondary changes in particle prop-
erties will affect penetration and internalization by cells. Also,
results obtained from cell culture conditions are not always
predictive for ex vivo or in vivo tissue studies. For example, in
previous studies on skin interactions with biodegradable
poly(lactic acid) (PLA) particles loaded with different fluores-
cent dyes, we found that although mono-dispersed and stable in
aqueous solution, skin contact with the particles lead to destabi-
lization with the release of loaded dyes [36,37].
The studies further illustrated that cells, especially immortal-
ized cell lines compared to primary cells as well as cell types,
e.g., epithelial cells versus dendritic cells, differ significantly in
their ability to take up nanomaterial. The choice of the experi-
mental system has a major influence on the generated informa-
tion and a thorough quality control of the behavior of different
particle batches in the experimental models is essential.
Nanoparticle-induced biological effects in
cells and whole skin
Titanium dioxide particles in sunscreens as well as silver
particles for skin surface antisepsis are usually intended to stay
on the skin surface. Although penetration of solid particles
across the intact skin barrier seems to be very limited, experi-
mental data strongly suggests that penetration is enhanced when
the skin barrier is disrupted, e.g., after physical, chemical,
inflammatory damage, or high UV exposure. Especially for
metal particles, which are designed to exhibit toxic effects
against microbes, collateral damage to healthy skin may
become a limiting factor.
To assess the overall influence of AgNP exposure on cell
viability, we investigated the influence of AgNP on cell metab-
olism in HaCaT cells by the XTT assay based on 2,3-bis(2-
methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-
2H-tetrazolium hydroxid (Figure 4a).
Interestingly, the XTT signal increased in cells incubated with
low concentrations of Ag (<20 µg/mL) but it decreased for cells
incubated with 40 µg/mL. When the serum concentration in the
cell culture media was reduced below the required amount of
9%, all concentrations of AgNP induced a reduction in cell
viability. This finding is relevant with regard to application,
because low concentrations of experimental nanoparticle prepa-
rations frequently require the addition of volumes which cause
secondary dilution of cell media. Also, it could indicate that
cells under suboptimal conditions are more prone to particle-
induced stress. Last but not least, possible interactions between
proteins in media may occur in a concentration-dependent
manner and influence the particle–cell interactions, which is
supported by our previous findings on the different aggregation
behaviors of particles in biological media. Changes in the
release of inflammatory cytokines and cell cycle alterations
were correlated with those findings (unpublished data). TEM
studies confirmed intracellular uptake of AgNP accumulation in
vesicles, most likely endosomes (Figure 2b).
Toxicity of metal particles is widely attributed to the produc-
tion of reactive oxygen species (ROS) [38] and oxidative stress.
Reported studies on nanoparticle-induced oxidative stress use
different read-outs for radical production including fluo-
rochromic assays [39], depletion of antioxidants [40], enzyme
activity (e.g., catalase [41], superoxide dismutase), or oxidative
DNA damage. For example, reactive oxygen species-mediated
DNA damage and apoptosis were detected in human skin
epidermal cells after exposure to nickel nanoparticles [42].
Phototoxicity of zinc oxide nanoparticles induced the genera-
tion of oxidative DNA damage during UVA and visible light ir-
radiation in keratinocytes [43]. Oxidative stress and skin cell
toxicity were also shown for iron oxide nanoparticles [44].
In our group, we established protocols for the detection of free
radicals in cells and in whole skin by electron paramagnetic
resonance (EPR) spectroscopy. To detect nanoparticle-induced
free radicals in cells, EPR on cell suspensions by using the spin
probe TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl) was
established. This semi-stable radical is a nitroxide and reacts
with short-living radicals, giving the hydroxylamine which is
EPR silent. The EPR signal of the spin probe decreases if radi-
cals are present. After the addition of TEMPO to living cells,
the EPR signal decreases slowly over time due to the metabo-
lism of the cells. An irradiation of the cells with light in the
UVB wavelength range induced additional radicals and
decreased the EPR intensity of TEMPO faster and more drasti-
cally compared to untreated cells. When 75 nm silica particles
with different surface charges were added to HaCaT cells, no
oxidative stress in the dark was observed. Furthermore, irradi-
ation with UV light showed no differences to the irradiated
control cells. In contrast, uncoated TiO2 added to cells
decreased TEMPO when irradiated with UVB (210 mJ/cm2),
which correlates with what has been shown in literature [45].
The data were correlated with the production of IL-6. UV-radia-
tion- and nanoparticle-induced intracellular free radical genera-
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Figure 4: Biological responses of skin tissue and skin cells to particle exposure. The viability of HaCaT cells after 1 h and 24 h incubation with AgNP
at different concentrations was assessed by using the XTT assay (a). HaCaT cells were incubated with 30 µg/mL of AgNP produced and stored under
ambient air conditions or in argon atmosphere, respectively, and investigated by means of EPR spectroscopy. The used spin marker TEMPO (5 µM)
becomes EPR-invisible when reacting with ROS (b). In order to analyze ROS production in whole skin, the EPR-signal intensity was monitored after
the application of TiO2 on porcine ear samples at two different concentrations: 40 mg/mL (NPs A), 400 mg/mL (NPs B) and after irradiation after
1 or 3 min UVB light (210 and 630 mJ/cm2, respectively) and respective controls (c). Similarly, the EPR signal of porcine skin was followed after the
topical application of AgNP (0.446 mg/mL) for 1 h. Control samples were treated with PBS only (d).
tion were measured in human keratinocytes by EPR spec-
troscopy [45]. This illustrated that EPR is able to measure
UVB- and NP-induced ROS production in HaCaT cells. In
contrast to fluorogenic assays, like the well-known dichloro-
fluorescein assay, which might be influenced by the light scat-
tering properties of NP, the EPR measurement represents an
alternative method to measure the oxidative effects of NP over-
coming possible NP-related artefacts.
The AgNP reduced the TEMPO after 1 h incubation time in
HaCaT cells through induced oxidative stress (Figure 4b). The
intercellular ROS production was dependent on the formation
and storage condition of the AgNP. If the AgNP were produced
under ambient air conditions, more ROS were formed compared
to AgNP which were produced and stored in an argon atmos-
phere. The oxygen in the ambient atmosphere is responsible for
the formation of Ag+ ions by oxidation of the metallic silver
nanoparticles. Silver ions are probably responsible for the
induction of oxidative stress. In the argon atmosphere (in the
absence of oxygen), the release of silver ions is strongly
suppressed [46].
Taking the results of the uptake and cell viability into account,
the data indicate that the silver ions formed during production
and/or storage are mainly responsible for the induced oxidative
stress and cell damage. The results are in accordance with
reports in the literature, e.g., differential tolerance to AgNP
depending on chloride concentrations and ionic strength and
Ag+-induced oxidative stress in E. coli was recently demon-
strated by Chambers et al. [41]. Biological responses to
nanoparticle exposure on the cellular level give valuable infor-
mation on possible hazardous effects of cellular particle uptake.
In the whole skin, however, interactions with the skin microen-
vironment are much more complex. Therefore we tried to vali-
date our in vitro findings by EPR analyses of porcine skin. Our
previous investigation showed that TiO2 leads to ROS produc-
tion of cells irradiated by UVB [45]. Thus, the same TiO2
particles that were used for cell experiments were investigated
on porcine ear skin. While UVB irradiation alone induced high
levels of free radicals detected by a marked decrease in EPR
signal, no ROS could be detected after particle application
alone. A lack of particle penetration with rather superficial
radical production in response to UVB exposure could be an ex-
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planation. Similarly, no free radical production was detected in
skin treated with silver nanoparticles (Figure 4d). Further
studies are ongoing to validate this technique on whole tissue.
Conclusion
In the presented studies, we tried to obtain a comprehensive
picture of nanoparticle–skin interactions for silica, titanium
dioxide and silver particles. Skin penetration studies suggest
that under ex vivo conditions, the vast amount of topically
applied solid nanoparticles stays on the skin surface, but
deeper penetration of smaller portions, e.g., on the single
particle level, is indicated by X-ray microscopy, Raman spec-
troscopy and flow cytometric studies on skin cells separated
after skin exposure to particles. Hair follicles are important
storage and putative entry sites. Penetration in biologically rele-
vant amounts may especially occur at the site of barrier
dysfunction. As a consequence, exposure of viable cells to
nanoparticles may increase when particles are applied on a
disturbed barrier, as it is found in patients with inflammatory
skin diseases, structural defects of the barrier and open wounds
or barrier dysfunction in response to excessive sunlight expo-
sure. We show that toxic effects of particles per se have to be
differentiated from secondary effects, e.g., ion release from
silver particles and that cellular particle uptake and biological
effects vary with experimental settings and cell type. The
combination of technologies and the joint discussion of results
enabled us to look at nanoparticle–skin interactions and the bio-
logical relevance of our findings from different angles.
Over the past years, the increased interest in nanoparticle inter-
actions with biological systems has led to a strong rise in publi-
cations in the field. Gathering and processing information has
become one of the biggest challenges. Our studies demonstrate
the value of interdisciplinary collaborations, in this case
physics, chemistry, pharmaceutical chemistry and medicine.
Experimental
Published work related to skin penetration
and cellular uptake of amorphous silica
particles
Skin penetration of fluorescent silica particles: Skin penetra-
tion of fluorescent silica particles was studied through fluores-
cence microscopy of cryosections obtained from human skin
samples treated with fluorescent silica particles. The single cell
suspensions were prepared after separation of epidermis from
the dermis by dispase digestion. For detailed investigation of
uptake by Langerhans cells, this population was enriched by
magnetic cell separation (MACS) using anti-BDCA-1 (anti-
CD1c) antibodies and a dendritic cell isolation kit provided by
Miltenyi Biotec, Bergisch Gladbach, Germany. The procedure
allows to collect highly enriched Langerhans cells from
epidermis (enrichment to 75–90% compared to 2–3% in unsep-
arated epidermis cell suspensions). Figure 1 (a,b,d,e) was modi-
fied with permission of the copyright holder from our recent
publication [3]. Further details can be found in the materials and
methods section of this publication.
X-ray microscopy of gold core silica particles: The X-ray
microscopy measurements (Figure 1c) were performed on the
PolLux scanning transmission STXM microscope at the Swiss
Light Source, Paul Scherrer Institut, Villigen, Switzerland. The
protocols for particle detection on human skin were newly
developed and published in detail in our publication [4]. A
detailed description of the protocols as well as larger sets of
data obtained with 94 and 161 nm gold core particles with silica
shells and 298 nm silica particles coated with a gold shell are
available in this publication.
Cellular uptake of functionalized silica particles and inter-
action with physiological media: Data presented in Figure 3
are part of a larger study on silica particles ranging between
42 nm and 200 nm in size due to functionalization with
(3-aminopropyl)triethoxysilane (APS) groups [3]. For cellular
uptake studies, HaCaT cells were cultured in 75 cm2 cell culture
flasks in RPMI supplemented with 1% penicillin/streptomycin,
2% glutamine and 10% fetal calf serum. The cells grown in an
incubator with 5% CO2, 100% humidity at 37 °C and incubated
with the different silica particles (10 μg/mL) for 2 h. Analysis
was performed by using flow cytometry and confocal laser
scanning microscopy. Figure 3 was modified with permission of
the copyright holder from our recent publication [3]. Further
details can be found in the material and method section of this
publication.
Original data related to skin penetration and
biological effects of silver and titanium
dioxide particles
Raman microspectroscopy of porcine skin: Raman micro-
scopic measurements were performed by using the skin com-
position analyzer (River Diagnostics, Model 3510, Rotterdam,
The Netherlands). The fingerprint region (400–2000 cm−1)
excited by near-infrared laser radiation (785 nm, 25 mW on the
skin) was used for sample analyses. Raman spectra were
recorded from the skin surface down to a depth of 50 µm, in
2 µm steps. The measurement time for one spectrum was 5 s.
The surface enhanced Raman scattering (SERS) signal as a
result of interaction between AgNPs and the porcine skin was
generated by using the same excitation conditions. The utilized
Raman microscope as well as the obtained spectra were
described in detail elsewhere [47,48]. Skin areas of 2 × 2 cm
were incubated with 40 µL of AgNP (1.19 mg/mL). Samples
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were stored for 16 h in a wet chamber in the incubator (37 °C,
5% CO2, 100% humidity). After the incubation time, the
samples were carefully cleaned with a tissue and one tape strip
was done. The investigation was performed with confocal
Raman microscopy. The porcine ears were obtained from
freshly butchered pigs and delivered right after the slaughter.
The ears were processed for the experiment within 24 h.
Transmission electron microscopy of HaCaT Cells: HaCaT
cells were incubated for 24 h with 25 µg/mL AgNP. After fixa-
tion with 2.5% glutaraldehyde and dehydration with increasing
concentrations of ethanol, cells were embedded in Epon resin.
The block was sectioned (80 nm) and the cells were observed
by means of a transmission electron microscope (Zeiss EM906).
Detection of silver particle-mediated production of reactive
oxygen specimen by EPR spectroscopy: The PVP-coated
silver nanoparticles were prepared as described in Loza et al.
[46]. They had a negative zeta-potential of −20 mV and a diam-
eter of the metallic core of 70 nm. They were either prepared
and stored under air, leading to some degree of oxidation, or
under argon [49]. To investigate the radical formation, the
HaCaT cells were seeded, washed and 1∙106 cells/mL were in-
cubated with 30 µg/mL of AgNP (O2, n = 6) and (Ar, n = 3) and
investigated by means of EPR spectroscopy as described in
Ahlberg et al. [50]. The used spin marker TEMPO (5 µM)
becomes EPR invisible when reacting with ROS. The EPR
signal intensity of TiO2-treated porcine ear samples was
measured with two different particles concentrations: 40 mg/mL
(NPs A), 400 mg/mL (NPs B) and after 1 min or after 3 min ir-
radiation with UVB light (210 and 630 mJ/cm2, respectively)
and respective controls, n = 3. Similarly, EPR signals were
assessed after 1 h of incubation of AgNP (0.446 mg/mL) on
porcine skin. The skin was afterwards incubated with topically
applied PCA (500 µM) for 5 min, a small sample (4.5 mm
diameter) was taken and positioned in an EPR cell with a
500 µm slot. This cell was placed in the EPR spectrometer
(MiniScope MS 200, Magnettech, Berlin, Germany). The
settings were as follows: microwave frequency 9.4 GHz,
microwave power 10 mW, central magnetic field 335 mT and
sweep time 20 s. As negative control a, a skin sample with a
diameter of 14 mm was incubated with PBS only. After an incu-
bation time of 1 h, a punch biopsy of 4.5 mm in diameter was
taken and placed in the EPR sprectometer.
Assessment of cell viability through XTT Assay: HaCaT cells
were cultured in 75 cm2 cell culture flasks in RPMI supple-
mented with 1% penicillin/streptomycin, 2% glutamine and
10% fetal calf serum. The cells were grown in an incubator with
5% CO2, 100% humidity at 37 °C. For the XTT assay
1·105 HaCaT cells/mL were seeded on a 96-well plate and incu-
bated with the particles after 24 h [50]. Cells were washed with
PBS to remove particles, which were not taken up. The XTT
solution (Roche Diagnostic, Meylan, France) was prepared and
added to the cells (50 µL/well). The absorbance was measured
after 3 h, by using a microplate reader 2300 EnSpire (Perkin
Elmer, Santa Clara, California, USA). Sample optical density
(OD) was measured at wavelengths of 492 nm and 650 nm
(reference wavelength).
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